Sangrix annual stock-based compensation
2018
2019
2020
2021
2022
2023
2024
Sangrix Stock-Based Compensation Growth & History (SGRX)
Sangrix's stock-based compensation was $73,230 for fiscal 2024.
View full Sangrix company overviewSangrix annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-06-30 | $73,230 | $5,959 | +8.86% |
| 2023 | 2023-06-30 | $67,271 | −$1.6M | −95.85% |
| 2022 | 2022-06-30 | $1.6M | −$267,087 | −14.14% |
| 2021 | 2021-06-30 | $1.9M | $958,950 | +103.09% |
| 2020 | 2020-06-30 | $930,223 | $930,223 | — |
| 2019 | 2019-06-30 | $0 | $0 | — |
| 2018 | 2018-06-30 | $0 | — | — |
Sangrix stock-based compensation trends
Over the last five fiscal years, Sangrix's stock-based compensation increased from $0 to $73,230, a change of $73,230.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sangrix source filings ↗